JMPHF (Leveljump Healthcare) Current Accrued Expense: $0.05 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Leveljump Healthcare Current Accrued Expense?

Leveljump Healthcare JMPHF Current Accrued Expense is $0.05 Mil as of Jun. 2026. The stock has 1 warning sign investors should review.

Leveljump Healthcare's Current Accrued Expense for the quarter that ended in Jun. 2026 was $0.05 Mil.

Leveljump Healthcare's quarterly Current Accrued Expense declined from Dec. 2025 ($-0.01 Mil) to Mar. 2026 ($-0.03 Mil) but then increased from Mar. 2026 ($-0.03 Mil) to Jun. 2026 ($0.05 Mil).

Leveljump Healthcare's annual Current Accrued Expense increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.02 Mil) but then declined from Dec. 2024 ($0.02 Mil) to Dec. 2025 ($-0.01 Mil).

Leveljump Healthcare Current Accrued Expense Related Terms

Leveljump Healthcare Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Leveljump Healthcare's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Leveljump Healthcare Current Accrued Expense Chart

Leveljump Healthcare Annual Data
Trend Aug19 Aug20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial 0.90 0.08 0.00 0.02 -0.01

Leveljump Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.06 -0.01 -0.03 0.05

Leveljump Healthcare Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.05 Mil mean?
Leveljump Healthcare (JMPHF) has a Current Accrued Expense of $0.05 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Leveljump Healthcare and its competitors.
Is Leveljump Healthcare's Current Accrued Expense too high?
Leveljump Healthcare's current Current Accrued Expense is $0.05 Mil.
How does Leveljump Healthcare's Current Accrued Expense compare to TMO and DHR?
Leveljump Healthcare's Current Accrued Expense of $0.05 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Diagnostics & Research company?
A good Current Accrued Expense depends on the Medical Diagnostics & Research industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Leveljump Healthcare and its competitors. Leveljump Healthcare's current Current Accrued Expense is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leveljump Healthcare stock overvalued right now?
Leveljump Healthcare (JMPHF) has a current Current Accrued Expense of $0.05 Mil. The stock's GF Value™ is $0.05, compared to a current price of $0.04 — trading 14.5% below its estimated fair value. The current Current Accrued Expense is $0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Leveljump Healthcare (JMPHF), the current Current Accrued Expense is $0.05 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Leveljump Healthcare Business Description

Other Exchanges JUMP:Canada
Address 52 Scarsdale Road, Suite 207, Toronto, ON, CAN, M3B 2R7
Leveljump Healthcare Corp is engaged in providing radiology services both by providing direct patient images and by providing Teleradiology services, which is the process of providing remote off-site reading of radiology scans such as CT, MRI, and X-ray. Its teleradiology services allow hospital staff to scan their emergency room patients, then page the company's radiologist on call, who can then remotely view, via a secured server, the images and diagnose the patient, and provide a report back to the hospital. Leveljump provides its direct-to-patient services at its Independent Healthcare Facilities (IHFs). The company operates as a single segment, with all of its core assets, intellectual property, and development work being conducted in Canada.